Sdudy the relationship between serum hepatitis B virus deoxyribonucleic acid and circulating dendritic cell subsets in patients with hepatitis B infection
-
摘要: 目的探讨慢性乙肝病毒感染者外周血树突状细胞(DCs)亚群【髓系DC(MDC)和浆细胞DC(PDC)】的变化与血清HBVDNA的关系。方法采集健康人和慢性乙肝病毒感染者外周静脉抗凝全血,利用荧光抗体标记和流式细胞仪检测外周血树突状细胞亚群(MDC的特异性标记为L ineage-HLA-DR+CD11 c+,PDC的特异性标记为L ineage-HLA-DR+CD123+);固相放免法定量检测血清乙型肝炎病毒标志。结果慢性乙肝病毒感染者外周血PDC相对平均百分率低于健康对照者,但缺少统计学意义,MDC相对数量在两者间没有差别;血清HBeAg阳性慢性乙型肝炎患者外周血PDC相对数量显著高(P<0.01)于HBeAg阴性患者和健康人(P<0.05),而在上述3组中MDC相对数量无差异(P=0.194)。结论HBV感染可导致患者的免疫功能改变,使机体产生免疫耐受或DC的凋亡;慢性乙型肝炎患者外周血PDC增加与HBeAg血清转换有关,提示PDC可能有抑制病毒的作用。Abstract: Objective To investigate the influence of serum HBVDNA levels on the characterizathion of circulating dendritic cell subsets in patients with chronic hepatitis B infection.Methods The plasmacytoid DC (DC2, Lineage-HLA-DR+CD123+) and non-IFN-alpha producingmyeloid DC (DC1, Lineage-HLA-DR+CD11c+) in fresh peripheral blood from chronic hepatitis B infection without any anti-viral treatment and healthy donors were enumerated by using four-color flow cytometry.The serological markers of hepatitis B virus were evaluated by solid phase radioimmunoassay (RIA) .Results Percentage of PDC in patientswith chronic hepatitis B was numerically decreased and subsequently Produce less than that of nomal controls, but without statistical difference.Further, serum HBeAg positive patients with chronic hepatitis B exhibited a significant increase in percentage of circulating PDC, compared with HBeAg negative patients and health donors (P<0.01;P<0.05, respectively) .And there is no significant difference of MDC in peripheral blood between chronic hepatitis B patients and nomal controls or among three groups above (P=0.194) .Conclusion The results suggested that the HBV infection may cause patient's immunity function change and lead to the immune tolerance or apoptosis;The percentage of peripheral PDC is associated with the HBeAg seroconversion and may plays a role on inhibition of HBV replication in patients with chronic hepatitis B.
-
Key words:
- Hepatitis B /
- chronic /
- dendritic cells /
- Subsets
-
[1]Hilleman MR.Overview of the pathogenesis, prophylaxis and thera-peusis of viral hepatitis B, with focus on reduction to practical appli-cations[J].Vaccine, 2001, 19∶1837-1848. [2]梁晓峰, 陈园生, 王晓军, 等.中国3岁以上人群乙型肝炎血清流行病学研究[J].中华流行病学杂志, 2005, 26∶655-658. [3]Lok AS, McMahon BJ.Chronic hepatitis B[J].Hepatology, 2001, 34∶1225-1241. [4]Banchereau J, Steinman RM.Dendritic cells and the control of im-munity[J].Nature, 1998, 392∶245-52. [5]Robinson SP, Patterson S, English N, et al.Human peripheralblood contains two distinct lineages of dendritic cells[J].Eur J Im-munol, 1999, 29∶2769-78. [6]Wang FS, Xing LH, Liu MX, et al.Dysfunction of peripheral blooddendritic cells from patients with chronic hepatitis B virusinfection[J].World J Gastroenterol, 2001, 7∶537-41. [7]Arima S, Akbar SM, Michitaka K, et al.Impaired function of anti-gen-presenting dendritic cells in patients with chronic hepatitis B:localization of HBV DNA and HBV RNA in blood DC by in situ hy-bridization[J].Int J Mol Med, 2003, 11∶169-74. [8]Beckebaum S, Cicinnati VR, Dworacki G, et al.Reduction in thecirculating pDC1/pDC2 ratio and impaired function of exvivogenerat-ed DC1 in chronic hepatitis B infection[J].Clin Immunol, 2002, 104∶138-50. [9]Van derMolen RG, Sprengers D, Binda RS, et al.Functional im-pairment of myeloid and plasmacytoid dendritic cells of patients withchronic hepatitis B[J].Hepatology, 2004, 40∶738-46. [10]Gabrilovich DI, Patterson S, Harvey JJ, et al.Defects in the functionof dendrentic cells in murine retroviral infection[J].Adv Exp MedBiol, 1995, 378∶469-472. [11] 中华医学会.病毒性肝炎防治方案[J].中华传染病杂志, 2001, 19:56-62. [12]Paul S, Kyung DP, Melissa R, et al.Absolute values of dendriticcell subsets in bone marrow, cord blood, and peripheral blood enu-merated by a novel method[J].Stem Cells, 2003, 21∶2962303. [13]Van der Molen RG, Spreagers D, Birda RS, et al.Functional im-pairmentin of myeloid and plasmacytiod dendritic cells of patientswith chronic hepatitis B[J].Hepatology, 2004, 40 (3) ∶738-746. [14]李若冰, 陈红松, 费然, 等.慢性乙型肝炎病人外周血树突细胞功能的研究[J].中华医学杂志, 2002, 82 (13) :887-890. [15]Kunitani H, Shimizu Y, Murata H, et al.Phenotypic analysis ofcirculating and intrahepatic dendritic cell subsets in patients withchronic liver diseases[J].J Hepatal, 2002, 36∶734-741. [16]Tavakoli S, Mederacke I, Herzog-Hauff S, et al.Peripheral blooddendritic cells are phenotypically and functionally intact in chronichepatitis B virus (HBV) infection[J].Clinical and Experim-entalImmunology, 2007, 151∶60-70. [17]Beckebaum S, Cicinnati VR, Dworacki G, et al.Reduction in thecirculating MDC/PDC ratio and impaired function of exvivor-gener-ated DC1 in chronic hepatitis B infection[J].Clinical Immunology, 2002, 104∶138-150. [18]Liu YJ.Dendritic cells subsets and lineagesand their functions in in-nate and adaptive[J].immunity Cell, 2001, 106∶259-262. [19]Munz C, Steinman RM, Fujii S.Dendritic cell maturation by innatelymphocytes∶coordinated stimulation of innate and adaptiveimmunity[J].J Exp Med, 2005, 202∶203-207. [20]骆抗先.乙型肝炎基础和临床[M].2版.北京:人民卫生出版社, 2001∶35.
本文二维码
计量
- 文章访问数: 2153
- HTML全文浏览量: 8
- PDF下载量: 817
- 被引次数: 0